If this email is not displaying properly, please View as Webpage
Wanted: Prescribers to Work with Local Communities
Earlier this year, State Targeted Response Technical Assistance (STR-TA) reached out to addiction specialists and providers with a minimum of two years’ experience prescribing medications in treating opioid use disorders (OUD), and more than 400 clinicians responded wanting to help. But more consultants are needed who practice in the states listed below.

The focus of the STR-TA initiative is to help address OUD and overdose deaths at the local level. STR-TA, funded by the Substance Abuse and Mental Health Services Administration, is made up of a broad coalition of organizations, led by the American Academy of Addiction Psychiatry, dedicated to mitigating the opioid misuse and overdose healthcare crisis.

Consultants will be vetted and available to respond to requests for education, training and mentoring needs in the community. These consultants will be compensated for their time.
Experience through the PCSS grant initiative showed that working at the local level is the most effective way to approach and address many of the barriers to treatment. Each region, each state, has unique issues that local practitioners will have expertise in. As requests come in, they are shared with local consultants, who work with the STR-TA team to solve problems at the community level.
STR-TA needs prescribers in the following states:
  • Arkansas
  • Delaware
  • Idaho
  • Kansas
  • Maine
  • Montana
  • North and South Dakota
  • Nebraska
  • Oklahoma
  • Wyoming
Learn how you can be part of this national effort to address the opioid use disorder healthcare crisis. Contact str-ta@aaap.org. 
PCSS Trainings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Motivational Interviewing: Brushing up on the Basics
Date: Tuesday, September 25, 2018
Time: 12:00 - 1:00 pm ET
Sponsor: American Psychiatric Association ( APA )
Presenter: Carla Marienfeld, MD, Associate Clinical Professor of Psychiatry, UC San Diego School of Medicine

Webinar description: This webinar will review the basic concepts and skills of Motivational Interviewing (MI) and will employ MI skills and tools, to illustrate the practical applicability of these tools in clinical practice for their addiction and other patient populations. An MI approach positions clinicians and patients as mutually collaborative experts, and participants adhering to MI can improve the efficiency of the limited clinical time we have with patients.  [Learn more]
American Psychiatric Association Archived Webinar

Main Results and Clinical Implications of the X:BOT Trial:
XR-Naltrexone vs. Buprenorphine-Naloxone Film
Webinar description: Opioid use disorder is a chronic relapsing disorder, conveying serious risks including disability, incarceration, transmission of blood-borne infections, and death from opioid overdose. There is now nearly a half century of overwhelming evidence that agonist substitution, initially with methadone and more recently with buprenorphine, is both efficacious in clinical trials and effective in the community in promoting and sustaining abstinence and reducing risks associated with opioid use disorder.  [Learn more]
Of Interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SAMHSA Releases Guide to Help Pregnant Women with OUD
The Substance Abuse and Mental Health Services Administration (SAMHSA) is releasing four Healthy Pregnancy, Healthy Baby fact sheets that offer treatment guidance for women who have opioid use disorders and who also are pregnant and/or are mothers of infants. The Healthy Pregnancy, Healthy Baby fact sheets explain the processes for treating opioid use disorder and neonatal abstinence syndrome. They give women the information they need to seek care and to successfully manage both pregnancy and opioid use disorder treatment.
Surgeon General Releases Spotlight on Opioids
This week, the Surgeon General released Facing Addiction in America: The Surgeon General’s Spotlight on Opioids, a condensed document with opioid-relevant content from the 2016 Surgeon General’s Report on Alcohol, Drugs, and Health. The Spotlight on Opioids calls for a cultural shift in the way Americans talk about the opioid crisis and recommends actions that can prevent and treat opioid misuse and promote recovery.  

The Surgeon General also released a digital postcard which is a call to action to the general public. Please share the 5 actions every person can do to stem the opioid epidemic.
FDA Takes Steps to Encourage Appropriate Prescribing of Opioids
The FDA approved the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS). This new plan includes several measures to help better communicate the serious risks about the use of opioid pain medications to patients and health care professionals. This expanded REMS now, for the first time, applies to immediate-release (IR) opioid analgesics intended for use in an outpatient setting. 
ACEP Offers CME Course: Treating Opioid Use Disorder in the ED
The purpose of this free E-QUAL Opioid Wave I webinar is to describe the use of medication-assisted treatments for opioid use disorder including non-opioid and opioid agonist therapies. This webinar provides up-to-date education on the latest ED quality improvement requirements in the diagnosis, prescribing, treatment, clinical skills and practice transformation innovations necessary for the practice of emergency medicine that relate to opioids care. Create a free account at ACEP and register.
News and Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PCSS Online Brochure. Please share this link with colleagues: https://goo.gl/G1ay6H
Funding for this initiative was made possible (in part) by grant nos. 5H79TI025595-03, 5U79TI026556-02 and 3U79TI026556-02S1 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.